NASDAQ · Financial Statements
Aptose Biosciences Inc. (APTO) Financial Statements
$1.71
NASDAQ: APTO
Market Cap $4.36M
Overview Financials Dividend Aptose Biosciences Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-65.0M $-43.0M $-52.0M $0 $0 Net Profit $-65.0M $-42.0M $-51.0M $-25.0M $0 EPS $-34.56 $-22.12 $-27.08 $-18.94 $-10.41 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $83.0M $51.0M $13.0M $10.0M $10.0M Total Liabilities $8.0M $13.0M $16.0M $15.0M $37.0M Cash $39.0M $37.0M $9.0M $6.0M $1.0M Borrowings $1.0M $1.0M $1.0M $11.0M $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-43.0M $-32.0M $-45.0M $-36.0M $0 Investing Cash Flow $-35.0M $30.0M $10.0M $0 $0 Financing Cash Flow $0 $0 $0 $0 $19.0M Net Cash Flow $-78.0M $-2.0M $-28.0M $-3.0M $-3.0M Free Cash Flow $-44.0M $-32.0M $-45.0M $-36.0M $0
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -2.33 FCF Yield 0.00% Quick Ratio 0.55 Interest Coverage -8.64 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock